Jardiance 25 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26FZ9X1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,704
Award facts
- Contract value 100% obligated
- $32,703.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,703.56 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order as a child contract under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
This delivery order supports the Defense Logistics Agency's pharmaceutical supply chain operations, providing Jardiance (empagliflozin), a diabetes medication, for use across military and federal healthcare systems. AmerisourceBergen's SPE2DX prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling supply of a wide range of medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal procurement portfolio demonstrates extensive capability in delivering both brand-name and generic pharmaceuticals across multiple therapeutic domains to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FZ9X1?
SPE2DR26FZ9X1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FZ9X1 worth?
The government has obligated $32,704 on SPE2DR26FZ9X1.
Is contract SPE2DR26FZ9X1 an order under another contract?
Yes. SPE2DR26FZ9X1 is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FZ9X1 competed?
The extent of competition for SPE2DR26FZ9X1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award